Decreased type I IFN response in B cells carrying the MS-protective class I alleles. by Christian Lundtoft (4068679)

Regions of significantly decreased ACM of SP-MS relative to RR-MS patients. by Mark Lyksborg (583318)

Overexpression of mC4 decreased membrane capacitance without altering overall excitability. by Ashley L. Comer (8299128)

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

Purified apolipoproteins decrease endothelial exocytosis. by Scott J. Cameron (838315)

Circulating APRIL levels are decreased in diabetic patients. by Adriana Carvalho-Santos (814114)

Subjects:

Definitions of the features selected [50]. by Yu Zhang (12946)

Subjects:

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)

PSD-95 decreased ASIC2a acid-evoked current. by Anne Marie S. Harding (546425)

Identification of proteins that presented a significant decrease in their expression content. by Rubens D. M. Magalhães (395962)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Dex decreases dispersal of GBM cells. by Stephen Shannon (784424)

Subjects:

Compound 1 decreased the ΔΨm level of HepG-2 cells. by Jing Zhang (23775)

Two fully automated segmentation pipelines used to determine change in whole brain volume. by Renxin Chu (5169857)

“…Images are from a 51-year-old man with relapsing-remitting multiple sclerosis at baseline and 4.5 years later; baseline disease duration = 30.1 years; baseline/follow-up Expanded Disability Status Scale score = 0/0, timed 25-foot walk = 5.0/4.0 seconds, and BPF = 0.802/0.798. PBVC was -0.9% (decreased) over the study period. …”

Trial profile. by Chanel Avenant (409756)

Subjects:

Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…<p>(a) Left: noise-evoked activity rates at different noise intensities for chronically tracked PPys cells in baseline and repeated stress conditions (<i>N</i> = 5 mice, <i>n</i> = 285 neurons, mean ± SE). Activity rates decreased during repeated stress compared to baseline (2-way ANOVA, condition F = 185.6, <i>p</i> = 4.8 × 10⁻⁴², condition: intensity interaction F = 10.37, <i>p</i> = 9.3 × 10⁻²¹, nested ANOVA (mouse nested within session), condition F = 174, <i>p</i> = 1.5 × 10⁻³⁹, condition: intensity interaction F = 12.7, <i>p</i> = 2 × 10⁻²⁶, post hoc for each level baseline versus repetitive stress <i>p</i> < 0.01 for all levels above 50 dB, all Bonferroni corrected). …”

Adenosine inhibits AMPA EPSCs by decreasing presynaptic glutamate release. by Shouping Wang (402959)

Rapamycin decreases phosphorylation of downstream targets of mTOR in the skin. by Lydia Jiménez-Díaz (44306)

“…</i> White arrows indicate double-labelled fibers. Note the overall decrease of phospho-S6K labelling after rapamycin injection. ep, epidermis; d, dermis. …”

Decreased oxidative phosphorylation in SDH and VHL-related PH/PGL. by Judith Favier (78711)

“…(D–F) Mean values for mitochondrial complexes II+III, III and IV reveal a generalized decrease in respiration in SDH and VHL PH/PGL. …”